BMRN DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Lawsuit by GlobeNewsWire | Dec 14, 2021 | Globe Newswire